Therapeutic Strategies for Combined-Modality Therapy of Locally Advanced-Stage Non–Small-Cell Lung Cancer: Rationale for Consolidation Docetaxel Therapy
References (30)
- et al.
SWOG 0023: A randomized phase III trial of cisplatin/etoposide (PE) plus radiation therapy followed by consolidation docetaxel then maintenance therapy with gefitinib or placebo in patients with locally advance unresectable stage III non-small cell lung cancer (NSCLC)
Lung Cancer
(2005) - et al.
Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: initial results of Southwest Oncology Group trial 9416 (Intergroup trial 0160)
J Thorac Cardiovasc Surg
(2001) - et al.
Phase III trial of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2P)non–small cell lung cancer (NSCLC): outcomes and implications for surgical management in North American Intergroup 0139 (RTOG 9309)
Lung Cancer
(2005) - et al.
Improved survival in stage III non-smallcell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial
J Natl Cancer Inst
(1996) - et al.
Radiotherapy alone versus combined chemotherapy and radiotherapy in non-resectable non-small cell lung cancer: first analysis of a randomized trial of 353 patients
J Natl Cancer Inst
(1991) Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials
Br Med J
(1995)- et al.
A randomized trial comparing pre-operative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer
N Engl J Med
(1994) - et al.
A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer
J Natl Cancer Inst
(1994) - et al.
Integration of novel therapeutics into combined modality therapy of locally advanced non-small cell lung cancer
Clin Cancer Res
(2005) - et al.
Combined-Modality Treatment of Non-Small Cell Lung Cancer
Activity of docetaxel in platinum-treated nonsmall cell lung cancer: results of a phase II multicenter trial
J Clin Oncol
(2000)
Prospective randomized trial of docetaxel versus best supportive care in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy
J Clin Oncol
(2000)
p53-independent apoptosis induced by paclitaxel through an indirect mechanism
Proc Natl Acad Sci U S A
(1997)
Bcl-2 phosphorylation and p27 induction as potential p53-independent mechanisms of apoptotic response to taxanes in nonsmall cell lung carcinoma
Proc Am Assoc Cancer Res
(1999)
Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer
Cancer Res
(1995)
Cited by (4)
A phase i trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cisplatin for dry stage III non-small-cell lung cancer (JCOG9901DI)
2012, Cancer Chemotherapy and PharmacologyMultimodality therapy for stage III NSCLC: Controversies, advances, and evolving approaches
2006, Advanced Studies in Medicine
Electronic forwarding or copying is a violation of US and International Copyright Laws.
Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by Cancer Information Group, ISSN #1525-7304, provided the appropriate fee is paid directly to Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923 USA 978-750-8400.
Copyright © 2005 Elsevier Inc. All rights reserved.